H. Lundbeck AS - Company Profile
Powered by 
All the data and insights you need on H. Lundbeck AS in one report.
$295
- Save hours of research time and resources with
our up-to-date H. Lundbeck AS Strategy Report
- Understand H. Lundbeck AS position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on H. Lundbeck AS’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 30 Mar 2022 | Sun Pharma Industries Enters into Licensing Agreement with Lundbeck | Licensing Agreement |
Sun Pharmaceutical Industries Ltd
|
H. Lundbeck AS |
| 14 Oct 2021 | Lundbeck Enters into Licensing Agreement with AprilBio | Licensing Agreement |
H. Lundbeck AS
|
Aprilbio Co Ltd
|
| 04 Aug 2021 | Rgenta Therapeutics Enters into Collaboration with Lundbeck | Partnership | - |
Rgenta Therapeutics Inc
H. Lundbeck AS |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer